Filter
2718
Filtered Results: 2718
Text search:
regulatory
control
Featured
Recommendations
240
New Publications
712
Language
Document type
No document type
1282
Studies & Reports
494
Guidelines
482
Manuals
180
Strategic & Response Plan
157
Fact sheets
62
Training Material
23
Situation Updates
22
Resource Platforms
6
Brochures
5
Infographics
3
Online Courses
2
Countries / Regions
Global
121
Kenya
101
India
91
Ethiopia
58
Nigeria
56
Latin America and the Carribbean
53
Sierra Leone
49
Western and Central Europe
49
South Africa
46
Uganda
46
Ghana
44
Liberia
43
Africa
40
Zambia
37
Tanzania
34
Nepal
33
Bangladesh
32
Namibia
31
Rwanda
28
Myanmar / Burma
28
Ukraine
27
Malawi
25
West and Central Africa
24
South–East Asia Region
24
East and Southern Africa
24
Syria
21
Philippines
21
Eastern Europe
20
Lesotho
19
Middle East and North Africa
18
Paraguay
18
Guinea
14
Zimbabwe
13
Cambodia
12
Asia
12
El Salvador
11
Mozambique
11
Congo, Democratic Republic of
11
Eastern Europe and Central Asia
11
Botswana
11
Argentina
10
Eswatini/ Swaziland
10
Western Pacific Region
9
Russia
9
South Sudan
9
Indonesia
9
Senegal
8
Cameroon
7
Brazil
7
Pakistan
7
Chile
6
USA
6
North America
6
Bolivia
6
Yemen
6
Colombia
5
Burkina Faso
5
Haiti
5
Venezuela
5
Spain
5
Moldova
5
Sudan
5
Tajikistan
4
Thailand
4
Albania
4
Jordan
4
Germany
4
Georgia
4
Angola
4
Chad
4
Somalia
4
Ecuador
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea-Bissau
3
United Kingdom
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Gambia
2
Kazakhstan
2
Iran
2
Saudi Arabia
2
Turkmenistan
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Honduras
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Guatemala
2
Turkey
1
Australia
1
Togo
1
China
1
Fiji
1
Kyrgyzstan
1
Niger
1
Uzbekistan
1
Burundi
1
Morocco
1
Qatar
1
Mauritania
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
1021
Clinical Guidelines
189
Public Health
179
Key Resources
151
Women & Child Health
94
Pharmacy & Technologies
71
Capacity Building
24
Toolboxes
COVID-19
274
AMR
177
HIV
168
TB
137
Pharmacy
119
Mental Health
118
Planetary Health
111
Rapid Response
96
Caregiver
92
NTDs
68
NCDs
58
Ebola & Marburg
54
Malaria
52
Global Health Education
46
Conflict
41
Health Financing Toolbox
38
Specific Hazards
35
Disability
31
Refugee
29
Natural Hazards
21
Zika
20
Polio
17
Cholera
9
Social Ethics
9
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t...
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to generate comparable data for their registering and labell...
THE REPUBLIC OF BOTSWANA | MINISTRY OF HEALTH | DEPARTMENT OF PUBLIC HEALTH | NATIONAL MALARIA CONTROL PROGRAMME
Globally, the cancer burden is rising, exerting significant strain on
populations and health systems at all levels of income. There are
concerted efforts towards enhancing access to comprehensive
cancer prevention and control initiatives.
Social and Behaviour Change Communication (SBCC) is essential for the effective control, prevention and elimination of malaria. The 2018–2030 Strategic Framework for Malaria SBCC guides countries and partners in strengthening capacities, refining strategies and sharing best practices, all of which...
The document provides detailed guidelines for managing cholera outbreaks, focusing on prevention, diagnosis, treatment, and control strategies. It emphasizes the importance of setting up Cholera Treatment Centers (CTCs), ensuring access to clean water, promoting hygiene, and utilizing oral rehydrati...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys...
